Fulcrum Therapeutics Inc (FULC)
3.005
-0.32
(-9.49%)
USD |
NASDAQ |
Nov 15, 14:26
Fulcrum Therapeutics Net Income (TTM): -20.23M for June 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | -20.23M |
| March 31, 2024 | -99.43M |
| December 31, 2023 | -97.34M |
| September 30, 2023 | -98.71M |
| June 30, 2023 | -98.44M |
| March 31, 2023 | -108.72M |
| December 31, 2022 | -109.87M |
| September 30, 2022 | -107.22M |
| June 30, 2022 | -104.20M |
| March 31, 2022 | -89.78M |
| December 31, 2021 | -80.85M |
| September 30, 2021 | -75.08M |
| Date | Value |
|---|---|
| June 30, 2021 | -73.33M |
| March 31, 2021 | -69.37M |
| December 31, 2020 | -70.82M |
| September 30, 2020 | -69.22M |
| June 30, 2020 | -66.80M |
| March 31, 2020 | -64.29M |
| December 31, 2019 | -82.68M |
| September 30, 2019 | -75.41M |
| June 30, 2019 | -67.81M |
| March 31, 2019 | -62.49M |
| December 31, 2018 | -32.59M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-109.87M
Minimum
Dec 2022
-20.23M
Maximum
Jun 2024
-83.49M
Average
-82.68M
Median
Dec 2019
Net Income (TTM) Benchmarks
| Bioventus Inc | -39.48M |
| Arcturus Therapeutics Holdings Inc | -62.64M |
| Johnson & Johnson | 14.68B |
| Entrada Therapeutics Inc | 54.95M |
| Tenon Medical Inc | -13.87M |